Wordt geladen...
Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
Progressive fibrosing interstitial lung diseases (ILDs) involve similar pathophysiological processes, indicating the potential for common approaches to treatment. Nintedanib (Ofev(®)), an intracellular tyrosine kinase inhibitor (TKI) with antifibrotic properties, was one of the first drugs approved...
Bewaard in:
| Gepubliceerd in: | Drugs |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer International Publishing
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8163683/ https://ncbi.nlm.nih.gov/pubmed/33765296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-021-01487-0 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|